This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Paxillin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (07:59, 17 September 2020) (edit) (undo)
 
Line 25: Line 25:
**[[4xgz]], [[4xh2]] – hPXN + antibody<br />
**[[4xgz]], [[4xh2]] – hPXN + antibody<br />
**[[1ow8]], [[1ow7]] – hPXN + focal adhesion kinase focal adhesion targeting domain <br />
**[[1ow8]], [[1ow7]] – hPXN + focal adhesion kinase focal adhesion targeting domain <br />
-
**[[5w93]] – PXN + P130CAS - mouse<br />
+
**[[5w93]] – mPXN + P130CAS - mouse<br />
*Paxillin LD4 (residues 20-41)
*Paxillin LD4 (residues 20-41)
Line 41: Line 41:
**[[5uwh]] – hPXN + RAN + CRM1 + RANBP1<br />
**[[5uwh]] – hPXN + RAN + CRM1 + RANBP1<br />
**[[3u3f]] – hPXN + tyrosine kinase PYK2 focal adhesion domain<br />
**[[3u3f]] – hPXN + tyrosine kinase PYK2 focal adhesion domain<br />
 +
**[[6jmu]] – mPXN + GIT1<br />
*Paxillin proline-rich region (residues 45-54)
*Paxillin proline-rich region (residues 45-54)

Current revision

Human paxillin LD4 domain complex (blue) with α-parvin (green), tetraethylene glycol, triethylene glycol and etylene glycol (PDB code 2vzi)

Drag the structure with the mouse to rotate

3D structures of paxillin

Updated on 17-September-2020

References

  1. ↑ Tumbarello DA, Brown MC, Turner CE. The paxillin LD motifs. FEBS Lett. 2002 Feb 20;513(1):114-8. PMID:11911889
  2. ↑ Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R, Reichman T, Nallasura V, Schwartz S, Faoro L, Wang YC, Girard L, Tretiakova MS, Ahmed S, Zumba O, Soulii L, Bindokas VP, Szeto LL, Gordon GJ, Bueno R, Sugarbaker D, Lingen MW, Sattler M, Krausz T, Vigneswaran W, Natarajan V, Minna J, Vokes EE, Ferguson MK, Husain AN, Salgia R. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res. 2008 Jan 1;68(1):132-42. doi: 10.1158/0008-5472.CAN-07-1998. PMID:18172305 doi:http://dx.doi.org/10.1158/0008-5472.CAN-07-1998

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Paxillin"
Personal tools